BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7545785)

  • 1. Antigen-binding sites dominate the surface properties of IgG antibodies.
    Wingren C; Hansson UB; Magnusson CG; Ohlin M
    Mol Immunol; 1995 Aug; 32(11):819-27. PubMed ID: 7545785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of surface properties of human IgA, IgE, IgG and IgM antibodies with identical and different specificities.
    Wingren C; Michaelsen TE; Magnusson CG; Hansson UB
    Scand J Immunol; 1996 Nov; 44(5):430-6. PubMed ID: 8947593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fab-PEG-Fab as a potential antibody mimetic.
    Khalili H; Godwin A; Choi JW; Lever R; Khaw PT; Brocchini S
    Bioconjug Chem; 2013 Nov; 24(11):1870-82. PubMed ID: 24073593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germline antibody recognition of distinct carbohydrate epitopes.
    Nguyen HP; Seto NO; MacKenzie CR; Brade L; Kosma P; Brade H; Evans SV
    Nat Struct Biol; 2003 Dec; 10(12):1019-25. PubMed ID: 14625588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 4-4-20 anti-fluorescyl IgG Fab' recognition of membrane bound hapten: direct evidence for the role of protein and interfacial structure.
    Leckband DE; Kuhl T; Wang HK; Herron J; Müller W; Ringsdorf H
    Biochemistry; 1995 Sep; 34(36):11467-78. PubMed ID: 7547875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fragmentation of immunoglobulin G.
    Andrew SM; Titus JA
    Curr Protoc Cell Biol; 2003 Feb; Chapter 16():Unit 16.4. PubMed ID: 18228421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-inflammatory activity of human IgA antibodies and their Fab alpha fragments: inhibition of IgG-mediated complement activation.
    Russell MW; Reinholdt J; Kilian M
    Eur J Immunol; 1989 Dec; 19(12):2243-9. PubMed ID: 2606139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoglobulin G structure and rheumatoid factor epitopes.
    Maibom-Thomsen SL; Trier NH; Holm BE; Hansen KB; Rasmussen MI; Chailyan A; Marcatili P; Højrup P; Houen G
    PLoS One; 2019; 14(6):e0217624. PubMed ID: 31199818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the in vitro and in vivo activities of IgG and F(ab')2 fragments of a mixture of three monoclonal anti-Her-2 antibodies.
    Spiridon CI; Guinn S; Vitetta ES
    Clin Cancer Res; 2004 May; 10(10):3542-51. PubMed ID: 15161714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis for the binding of an anti-cytochrome c antibody to its antigen: crystal structures of FabE8-cytochrome c complex to 1.8 A resolution and FabE8 to 2.26 A resolution.
    Mylvaganam SE; Paterson Y; Getzoff ED
    J Mol Biol; 1998 Aug; 281(2):301-22. PubMed ID: 9698550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fc-dependent IgG-mediated suppression of the antibody response: fact or artefact?
    Heyman B
    Scand J Immunol; 1990 May; 31(5):601-7. PubMed ID: 1693227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surface properties of antigen-antibody complexes.
    Wingren C; Hansson UB
    Scand J Immunol; 1997 Aug; 46(2):159-67. PubMed ID: 9583996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conformational isomerism of IgG antibodies.
    Hansson UB; Wingren C; Alkner U
    Biochim Biophys Acta; 1997 Jun; 1340(1):53-62. PubMed ID: 9217014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycosylation of the variable region of immunoglobulin G--site specific maturation of the sugar chains.
    Endo T; Wright A; Morrison SL; Kobata A
    Mol Immunol; 1995 Sep; 32(13):931-40. PubMed ID: 7476998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human IgG anti-F(ab')2 antibodies possess rheumatoid factor activity.
    Hunt Gerardo S; Persselin JE; Stevens RH
    Clin Exp Immunol; 1990 Aug; 81(2):293-300. PubMed ID: 1696866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Basis of Assembly and Activation of Complement Component C1 in Complex with Immunoglobulin G1 and Antigen.
    Wang G; de Jong RN; van den Bremer ET; Beurskens FJ; Labrijn AF; Ugurlar D; Gros P; Schuurman J; Parren PW; Heck AJ
    Mol Cell; 2016 Jul; 63(1):135-45. PubMed ID: 27320199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The binding of protein A of immunoglobulin G and of Fab and Fc fragments.
    Endresen C
    Acta Pathol Microbiol Scand C; 1979 Jun; 87C(3):185-9. PubMed ID: 484238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of random and oriented immobilisation of antibody fragments on mixed self-assembled monolayers.
    Bonroy K; Frederix F; Reekmans G; Dewolf E; De Palma R; Borghs G; Declerck P; Goddeeris B
    J Immunol Methods; 2006 May; 312(1-2):167-81. PubMed ID: 16674973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A broad range of Fab stabilities within a host of therapeutic IgGs.
    Garber E; Demarest SJ
    Biochem Biophys Res Commun; 2007 Apr; 355(3):751-7. PubMed ID: 17321501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The binding of monoclonal antibodies to cell-surface molecules. A quantitative analysis with immunoglobulin G against two alloantigenic determinants of the human transplantation antigen HLA-A2.
    Ways JP; Parham P
    Biochem J; 1983 Nov; 216(2):423-32. PubMed ID: 6197968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.